Luciano José Megale Costa (Luciano J Costa, Luciano Costa)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 85

Top Venues

Blood cancer journal

British journal of haematology

The New England journal of medicine

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Ajai Chari, Jonathan L Kaufman, Jacob P Laubach, Douglas W Sborov, Brandi N Reeves, Cesar Rodriguez, Rebecca Silbermann, Luciano José Megale Costa, Larry D Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Peter M Voorhees, Saad Z Usmani, Paul Gerard Richardson
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN. Blood cancer journal 14 (1) (2024)
Rebecca Silbermann, Jacob Laubach, Jonathan L Kaufman, Douglas W Sborov, Brandi N Reeves, Cesar Rodriguez, Ajai Chari, Luciano José Megale Costa, Larry D Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej Jakubowiak, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Katharine S Gries, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Peter M Voorhees, Saad Z Usmani, Paul Gerard Richardson
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN. American journal of hematology 99 (7) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Luciano José Megale Costa, Thomas William LeBlanc, Hans Tesch, Pieter Sonneveld, Ryan P Kyle, Liliya Sinyavskaya, Patrick Hlavacek, Aster Meche, Jinma Ren, Alex Schepart, Didem Aydin, Guido Nador, Marco daCosta DiBonaventura
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma. Future oncology (London, England) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Gayathri Ravi, Susan Bal, Laura Joiner, Smith Giri, Melissa Sentell, Tiffany Hill, Kelly N Godby, Luciano José Megale Costa
Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations. British journal of haematology 204 (4) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Gayathri Ravi, Susan Bal, Laura Joiner, Smith Giri, Melissa Sentell, Tiffany Hill, Kelly N Godby, Luciano José Megale Costa
Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations. British journal of haematology (2024)
Sikander Ailawadhi, Bertrand Arnulf, Krina K Patel, Michele Cavo, Ajay K Nooka, Salomon Manier, Natalie S Callander, Luciano José Megale Costa, Ravi Vij, Nizar J Bahlis, Philippe Moreau, Scott R Solomon, Ingerid Weum Abrahamsen, Rachid C Baz, Annemiek Broijl, Christine Chen, Sundar Jagannath, Noopur Raje, Christof Scheid, Michel Delforge, Reuben Benjamin, Thomas Pabst, Shinsuke Iida, Jesus G Berdeja, Sergio A Giralt, Anna Truppel-Hartmann, Yanping Chen, Xiaobo Zhong, Fan Wu, Julia Piasecki, Laurie Eliason, Devender S Dhanda, Jasper Felten, Andrea Caia, Mark Cook, Mihaela Popa-Mckiver, Paula Rodriguez Otero
Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses. Blood (2024)
Rebecca Silbermann, Jacob Laubach, Jonathan L Kaufman, Douglas W Sborov, Brandi N Reeves, Cesar Rodriguez, Ajai Chari, Luciano José Megale Costa, Larry D Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej Jakubowiak, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Katharine S Gries, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Peter M Voorhees, Saad Z Usmani, Paul Gerard Richardson
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN. American journal of hematology 99 (7) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Luciano José Megale Costa, Thomas William LeBlanc, Hans Tesch, Pieter Sonneveld, Ryan P Kyle, Liliya Sinyavskaya, Patrick Hlavacek, Aster Meche, Jinma Ren, Alex Schepart, Didem Aydin, Guido Nador, Marco daCosta DiBonaventura
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma. Future oncology (London, England) 20 (17) (2024)
Gayathri Ravi, Susan Bal, Laura Joiner, Smith Giri, Melissa Sentell, Tiffany Hill, Kelly N Godby, Luciano José Megale Costa
Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations. British journal of haematology 204 (4) (2024)
Ajai Chari, Jonathan L Kaufman, Jacob P Laubach, Douglas W Sborov, Brandi N Reeves, Cesar Rodriguez, Rebecca Silbermann, Luciano José Megale Costa, Larry D Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Peter M Voorhees, Saad Z Usmani, Paul Gerard Richardson
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN. Blood cancer journal 14 (1) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Rebecca Silbermann, Jacob Laubach, Jonathan L Kaufman, Douglas W Sborov, Brandi N Reeves, Cesar Rodriguez, Ajai Chari, Luciano José Megale Costa, Larry D Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej Jakubowiak, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Katharine S Gries, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Peter M Voorhees, Saad Z Usmani, Paul Gerard Richardson
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN. American journal of hematology (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Narendranath Epperla, Ying Huang, Amanda F Cashen, John L Vaughn, Walter Hanel, Talha Badar, Stefan K Barta, Paolo F Caimi, Tarsheen K Sethi, Nishitha Reddy, Reem Karmali, Celeste Bello, Julio C Chavez, Shalin K Kothari, Francisco J Hernandez-Ilizaliturri, Jakub Svoboda, Frederick Lansigan, Martha J Glenn, Jonathon B Cohen, Caryn Sorge, Beth Christian, Alex F Herrera, Mehdi Hamadani, Luciano José Megale Costa, Ana C Xavier
Evaluation of prognostic factors for high-risk classical Hodgkin lymphoma undergoing autologous transplantation. Blood advances (2024)
Ajai Chari, Jonathan L Kaufman, Jacob P Laubach, Douglas W Sborov, Brandi N Reeves, Cesar Rodriguez, Rebecca Silbermann, Luciano José Megale Costa, Larry D Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Peter M Voorhees, Saad Z Usmani, Paul Gerard Richardson
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN. Blood cancer journal 14 (1) (2024)
Luciano José Megale Costa, Thomas William LeBlanc, Hans Tesch, Pieter Sonneveld, Ryan P Kyle, Liliya Sinyavskaya, Patrick Hlavacek, Aster Meche, Jinma Ren, Alex Schepart, Didem Aydin, Guido Nador, Marco daCosta DiBonaventura
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma. Future oncology (London, England) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Luciano José Megale Costa, Thomas William LeBlanc, Hans Tesch, Pieter Sonneveld, Ryan P Kyle, Liliya Sinyavskaya, Patrick Hlavacek, Aster Meche, Jinma Ren, Alex Schepart, Didem Aydin, Guido Nador, Marco daCosta DiBonaventura
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma. Future oncology (London, England) 20 (17) (2024)
Ajai Chari, Jonathan L Kaufman, Jacob P Laubach, Douglas W Sborov, Brandi N Reeves, Cesar Rodriguez, Rebecca Silbermann, Luciano José Megale Costa, Larry D Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Peter M Voorhees, Saad Z Usmani, Paul Gerard Richardson
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN. Blood cancer journal 14 (1) (2024)
Rebecca Silbermann, Jacob Laubach, Jonathan L Kaufman, Douglas W Sborov, Brandi N Reeves, Cesar Rodriguez, Ajai Chari, Luciano José Megale Costa, Larry D Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej Jakubowiak, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Katharine S Gries, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Peter M Voorhees, Saad Z Usmani, Paul Gerard Richardson
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN. American journal of hematology 99 (7) (2024)
Luciano José Megale Costa, Thomas William LeBlanc, Hans Tesch, Pieter Sonneveld, Ryan P Kyle, Liliya Sinyavskaya, Patrick Hlavacek, Aster Meche, Jinma Ren, Alex Schepart, Didem Aydin, Guido Nador, Marco daCosta DiBonaventura
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma. Future oncology (London, England) 20 (17) (2024)
Susan Bal, Luciano José Megale Costa
Bridging treatment prior to chimeric antigen receptor T-cell therapy in multiple myeloma. British journal of haematology (2023)
Luciano José Megale Costa, Smith Giri, Susan Bal, Gayathri Ravi, Kelly N Godby
Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma. British journal of haematology (2023)
Laura Joiner, Susan Bal, Kelly N Godby, Luciano José Megale Costa
Teclistamab in patients with multiple myeloma and impaired renal function. American journal of hematology (2023)
Jesús San-Miguel, Binod Dhakal, Kwee Yong, Andrew Spencer, Sébastien Anguille, María-Victoria Mateos, Carlos Fernández de Larrea, Joaquín Martínez-López, Philippe Moreau, Cyrille Touzeau, Xavier Leleu, Irit Avivi, Michele Cavo, Tadao Ishida, Seok Jin Kim, Wilfried Roeloffzen, Niels W C J van de Donk, Dominik Dytfeld, Surbhi Sidana, Luciano José Megale Costa, Albert Oriol, Rakesh Popat, Abdullah M Khan, Yaël C Cohen, P Joy Ho, James Griffin, Nikoletta Lendvai, Carolina Lonardi, Ana Slaughter, Jordan M Schecter, Carolyn C Jackson, Kaitlyn Connors, Katherine Li, Enrique Zudaire, Diana Chen, Jane Gilbert, Tzu-Min Yeh, Sarah Nagle, Erika Florendo, Lida Pacaud, Nitin Patel, Simon J Harrison, Hermann Einsele
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma. The New England journal of medicine (2023)
Susan Bal, Noel Estrada-Merly, Luciano José Megale Costa, Muzaffar H Qazilbash, Shaji K Kumar, Anita D'Souza
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies. Blood cancer journal 13 (1) (2023)
Paula Rodriguez-Otero, Sikander Ailawadhi, Bertrand Arnulf, Krina Patel, Michele Cavo, Ajay K Nooka, Salomon Manier, Natalie Callander, Luciano José Megale Costa, Ravi Vij, Nizar J Bahlis, Philippe Moreau, Scott R Solomon, Michel Delforge, Jesus Berdeja, Anna Truppel-Hartmann, Zhihong Yang, Linda Favre-Kontula, Fan Wu, Julia Piasecki, Mark Cook, Sergio Giralt
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma. The New England journal of medicine (2023)
Meera Mohan, Rajshekhar Chakraborty, Susan Bal, Anoma Nellore, Muhamed Baljevic, Anita D Souza, Peter G Pappas, Jesus G Berdeja, Natalie Callander, Luciano José Megale Costa
Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma. British journal of haematology (2023)
Paula Rodriguez-Otero, Sikander Ailawadhi, Bertrand Arnulf, Krina Patel, Michele Cavo, Ajay K Nooka, Salomon Manier, Natalie Callander, Luciano José Megale Costa, Ravi Vij, Nizar J Bahlis, Philippe Moreau, Scott R Solomon, Michel Delforge, Jesus Berdeja, Anna Truppel-Hartmann, Zhihong Yang, Linda Favre-Kontula, Fan Wu, Julia Piasecki, Mark Cook, Sergio Giralt
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma. The New England journal of medicine 388 (11) (2023)
Luciano José Megale Costa, Smith Giri, Susan Bal, Gayathri Ravi, Kelly N Godby
Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma. British journal of haematology 200 (6) (2023)
Maria-Victoria Mateos-Manteca, Sikandar Ailawadhi, Luciano José Megale Costa, Shakira J Grant, Lalit Kumar, Florent Malard, Didem Aydin, Saad Z Usmani
Global disparities in patients with multiple myeloma: a rapid evidence assessment. Blood cancer journal 13 (1) (2023)
Luciano José Megale Costa, Smith Giri, Susan Bal, Gayathri Ravi, Kelly N Godby
Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma. British journal of haematology 200 (6) (2023)
Paula Rodriguez-Otero, Sikander Ailawadhi, Bertrand Arnulf, Krina Patel, Michele Cavo, Ajay K Nooka, Salomon Manier, Natalie Callander, Luciano José Megale Costa, Ravi Vij, Nizar J Bahlis, Philippe Moreau, Scott R Solomon, Michel Delforge, Jesus Berdeja, Anna Truppel-Hartmann, Zhihong Yang, Linda Favre-Kontula, Fan Wu, Julia Piasecki, Mark Cook, Sergio Giralt
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma. The New England journal of medicine 388 (11) (2023)
Luciano José Megale Costa, Smith Giri, Susan Bal, Gayathri Ravi, Kelly N Godby
Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma. British journal of haematology 200 (6) (2023)
Paula Rodriguez-Otero, Sikander Ailawadhi, Bertrand Arnulf, Krina Patel, Michele Cavo, Ajay K Nooka, Salomon Manier, Natalie Callander, Luciano José Megale Costa, Ravi Vij, Nizar J Bahlis, Philippe Moreau, Scott R Solomon, Michel Delforge, Jesus Berdeja, Anna Truppel-Hartmann, Zhihong Yang, Linda Favre-Kontula, Fan Wu, Julia Piasecki, Mark Cook, Sergio Giralt
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma. The New England journal of medicine 388 (11) (2023)
Ghulam Rehman Mohyuddin, Rohan Kapur, Luciano José Megale Costa
Inclusion criteria of currently enrolling T-cell engaging trials in multiple myeloma: Should we be focusing on lines of prior therapy? British journal of haematology (2023)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Faith E Davies, Charlotte Pawlyn, Saad Z Usmani, Jesús San F Miguel, Hermann Einsele, Eileen Mary Boyle, Jill Corre, Daniel Auclair, Hearn Jay Cho, Sagar Lonial, Pieter Sonneveld, A Keith Stewart, Peter Leif Bergsagel, Martin F Kaiser, Katja Weisel, Jonathan J Keats, Joseph R Mikhael, Kathryn E Morgan, Irene M Ghobrial, Robert Z Orlowski, Carl Ola Landgren, Francesca Gay, Joseph Caers, Wee-Joo Chng, Ajai Chari, Brian A Walker, Shaji K Kumar, Luciano José Megale Costa, Kenneth C Anderson, Gareth J Morgan
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma. Blood cancer discovery 3 (4) (2022)
Ajai Chari, Monique C Minnema, Jesus G Berdeja, Albert Oriol, Niels W C J van de Donk, Paula Rodríguez-Otero, Elham Askari, María-Victoria Mateos, Luciano José Megale Costa, Jo Caers, Raluca Verona, Suzette Girgis, Shiyi Yang, Rachel B Goldsmith, Xiang Yao, Kodandaram Pillarisetti, Brandi W Hilder, Jeffery Russell, Jenna D Goldberg, Amrita Krishnan
Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma. The New England journal of medicine 387 (24) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ajai Chari, Monique C Minnema, Jesus G Berdeja, Albert Oriol, Niels W C J van de Donk, Paula Rodríguez-Otero, Elham Askari, María-Victoria Mateos, Luciano José Megale Costa, Jo Caers, Raluca Verona, Suzette Girgis, Shiyi Yang, Rachel B Goldsmith, Xiang Yao, Kodandaram Pillarisetti, Brandi W Hilder, Jeffery Russell, Jenna D Goldberg, Amrita Krishnan
Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma. The New England journal of medicine 387 (24) (2022)
Luciano José Megale Costa, Vania Tietsche de Moraes Hungria, Mohamad Mohty, Maria-Victoria Mateos-Manteca
How I treat triple-class refractory multiple myeloma. British journal of haematology 198 (2) (2022)
Susan Bal, Binod Dhakal, Rebecca W Silbermann, Timothy M Schmidt, Bhagirathbhai Dholaria, Smith Giri, Saurabh Chhabra, Eva Medvedova, Kelly N Godby, Anita D Souza, Aric C Hall, Pamela Hardwick, Jim Omel, Robert F Cornell, Parameswaran Hari, Natalie S Callander, Luciano José Megale Costa
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapy. American journal of hematology 97 (9) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ajai Chari, Monique C Minnema, Jesus G Berdeja, Albert Oriol, Niels W C J van de Donk, Paula Rodríguez-Otero, Elham Askari, María-Victoria Mateos, Luciano José Megale Costa, Jo Caers, Raluca Verona, Suzette Girgis, Shiyi Yang, Rachel B Goldsmith, Xiang Yao, Kodandaram Pillarisetti, Brandi W Hilder, Jeffery Russell, Jenna D Goldberg, Amrita Krishnan
Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma. The New England journal of medicine 387 (24) (2022)
Smith Giri, Susan Bal, Kelly N Godby, Gayathri Ravi, Deanna Clark, Clare Ubersax, Abigail Cooley, Priscila White, Sunil Rangarajan, Grant R Williams, Luciano José Megale Costa
Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myeloma. American journal of hematology 97 (4) (2022)
Ajai Chari, Monique C Minnema, Jesus G Berdeja, Albert Oriol, Niels W C J van de Donk, Paula Rodríguez-Otero, Elham Askari, María-Victoria Mateos, Luciano José Megale Costa, Jo Caers, Raluca Verona, Suzette Girgis, Shiyi Yang, Rachel B Goldsmith, Xiang Yao, Kodandaram Pillarisetti, Brandi W Hilder, Jeffery Russell, Jenna D Goldberg, Amrita Krishnan
Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma. The New England journal of medicine 387 (24) (2022)
Gayathri Ravi, Luciano José Megale Costa
Bispecific T-cell engagers for treatment of multiple myeloma. American journal of hematology (2022)
Ajai Chari, Monique C Minnema, Jesus G Berdeja, Albert Oriol, Niels W C J van de Donk, Paula Rodríguez-Otero, Elham Askari, María-Victoria Mateos, Luciano José Megale Costa, Jo Caers, Raluca Verona, Suzette Girgis, Shiyi Yang, Rachel B Goldsmith, Xiang Yao, Kodandaram Pillarisetti, Brandi W Hilder, Jeffery Russell, Jenna D Goldberg, Amrita Krishnan
Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma. The New England journal of medicine (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Douglas W Sborov, Muhamed Baljevic, Brandi Reeves, Jacob P Laubach, Yvonne A Efebera, Cesar Rodriguez, Luciano José Megale Costa, Ajai Chari, Rebecca Silbermann, Sarah A Holstein, Larry D Anderson, Jonathan L Kaufman, Nina Shah, Huiling Pei, Sharmila Patel, Annelore Cortoos, J Blake Bartlett, Jessica Vermeulen, Thomas S Lin, Peter M Voorhees, Paul Gerard Richardson
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study. British journal of haematology 199 (3) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ajai Chari, Monique C Minnema, Jesus G Berdeja, Albert Oriol, Niels W C J van de Donk, Paula Rodríguez-Otero, Elham Askari, María-Victoria Mateos, Luciano José Megale Costa, Jo Caers, Raluca Verona, Suzette Girgis, Shiyi Yang, Rachel B Goldsmith, Xiang Yao, Kodandaram Pillarisetti, Brandi W Hilder, Jeffery Russell, Jenna D Goldberg, Amrita Krishnan
Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma. The New England journal of medicine 387 (24) (2022)
Ajai Chari, Monique C Minnema, Jesus G Berdeja, Albert Oriol, Niels W C J van de Donk, Paula Rodríguez-Otero, Elham Askari, María-Victoria Mateos, Luciano José Megale Costa, Jo Caers, Raluca Verona, Suzette Girgis, Shiyi Yang, Rachel B Goldsmith, Xiang Yao, Kodandaram Pillarisetti, Brandi W Hilder, Jeffery Russell, Jenna D Goldberg, Amrita Krishnan
Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma. The New England journal of medicine 387 (24) (2022)
Luciano José Megale Costa, Faith E Davies, Gregory P Monohan, Tibor Kovacsovics, Nicholas Burwick, Andrzej Jakubowiak, Jonathan L Kaufman, Wan-Jen Hong, Monique Dail, Ahmed Hamed Salem, Xiaoqing Yang, Abdullah A Masud, Wijith Munasinghe, Jeremy A Ross, Orlando F Bueno, Shaji K Kumar, Edward A Stadtmauer
Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma. Blood advances 5 (19) (2021)
Omer H Jamy, Richard Godby, Aditi Dhir, Luciano José Megale Costa, Ana C Xavier
Impact of insurance status on the survival of younger patients diagnosed with acute promyelocytic leukemia in the United States. Cancer 127 (16) (2021)
Christianne Tolêdo de Souza Leal, Luciano José Megale Costa, Juliana Pereira, Fernando Barroso Duarte, Raphael Barros Tavares, Angelo Atalla, Bruna Sousa Sabioni, Abrahão Elias Hallack Neto
Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients. Bone marrow transplantation (2021)
Omer H Jamy, Alice Chen, Kevin Battles, Liton Francisco, Donna Salzman, Susan Bal, Antonio Di Stasi, Luciano José Megale Costa, Ravi Bhatia, Smita Bhatia
Impact of access to care on 1-year mortality following allogeneic blood or marrow transplantation. Bone marrow transplantation 56 (6) (2021)
Luciano José Megale Costa, Saurabh Chhabra, Eva Medvedova, Bhagirathbhai R Dholaria, Timothy Martin Schmidt, Kelly N Godby, Rebecca W Silbermann, Binod Dhakal, Susan Bal, Smith Giri, Anita D Souza, Aric C Hall, Pamela Hardwick, James Omel, Robert Frank Cornell, Parameswaran N Hari, Natalie S Callander
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2021)
Omer H Jamy, Raquel Innis-Shelton, Susan Bal, Ravi Paluri, Donna Salzman, Antonio Di Stasi, Luciano José Megale Costa, Ruby Meredith, Lawrence Lamb, Kentaro Minagawa, Shin Mineishi, Ayman Saad
Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation. American journal of hematology 96 (10) (2021)
Susan Bal, Smith Giri, Kelly N Godby, Luciano José Megale Costa
Impact of t(11;14) as a sole and concomitant abnormality on outcomes in multiple myeloma. British journal of haematology 195 (1) (2021)
Omer H Jamy, Aditi Dhir, Luciano José Megale Costa, Ana C Xavier
Impact of sociodemographic factors on early mortality in acute promyelocytic leukemia in the United States: A time-trend analysis. Cancer (2021)
Luciano José Megale Costa, Benjamin A Derman, Susan Bal, Surbhi Sidana, Saurabh Chhabra, Rebecca Silbermann, Jing C Ye, Curly T C M Morris, Robert F Cornell, Sarah A Holstein, Qian Shi, James Omel, Natalie S Callander, Wee Joo Chng, Vania Hungria, Ângelo Maiolino, Edward Stadtmauer, Sergio A Giralt, Marcelo Pasquini, Andrzej J Jakubowiak, Gareth J Morgan, Amrita Krishnan, Graham H Jackson, Mohamad Mohty, Maria-Victoria Mateos-Manteca, Meletious A Dimopoulos, Thierry Facon, Andrew Spencer, Jesus San Miguel, Parameswaran Hari, Saad Z Usmani, Salomon Manier, Phillip McCarthy, Shaji K Kumar, Francesca Gay, Juan José Lahuerta
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials. Leukemia 35 (1) (2020)
Luciano José Megale Costa, Simona Iacobelli, Marcelo C Pasquini, Riddhi Modi, Luisa Giaccone, Joan Blade, Stefan Schonland, Andrea Evangelista, Jose A Perez-Simon, Parameswaran Hari, Elizabeth E Brown, Sergio A Giralt, Francesca Patriarca, Edward A Stadtmauer, Laura Rosinol, Amrita Y Krishnan, Gösta Gahrton, Benedetto Bruno
Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation. Bone marrow transplantation 55 (9) (2020)
Susan Bal, Luciano José Megale Costa
Age is just a number, the wrong number. Cancer 126 (23) (2020)
Ajai Chari, Dan T Vogl, Maria Gavriatopoulou, Ajay K Nooka, Andrew J Yee, Carol A Huff, Philippe Moreau, David Dingli, Craig Cole, Sagar Lonial, Meletios Dimopoulos, A Keith Stewart, Joshua Richter, Ravi Vij, Sascha Tuchman, Marc S Raab, Katja C Weisel, Michel Delforge, Robert F Cornell, David Kaminetzky, James E Hoffman, Luciano José Megale Costa, Terri L Parker, Moshe Levy, Martin Schreder, Nathalie Meuleman, Laurent Frenzel, Mohamad Mohty, Sylvain Choquet, Gary Schiller, Raymond L Comenzo, Monika Engelhardt, Thomas Illmer, Philip Vlummens, Chantal Doyen, Thierry Facon, Lionel Karlin, Aurore Perrot, Klaus Podar, Michael G Kauffman, Sharon Shacham, Lingling Li, Shijie Tang, Carla Picklesimer, Jean-Richard Saint-Martin, Marsha Crochiere, Hua Chang, Samir Parekh, Yosef Landesman, Jatin Shah, Paul G Richardson, Sundar Jagannath
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma. The New England journal of medicine 381 (8) (2019)
Susan Bal, Allison Weaver, Robert Frank Cornell, Luciano José Megale Costa
Challenges and opportunities in the assessment of measurable residual disease in multiple myeloma. British journal of haematology 186 (6) (2019)
Yara Abrão Vasconcelos Vivas, Vânia Tietsche de Moraes Hungria, Luciano José Megale Costa, Kelli Borges Dos Santos, Alfredo Chaoubah, Maria Teresa Bustamante-Teixeira, Leonardo Peres Vivas, Angelo Maiolino, Abrahão Elias Hallack Neto
Up-front autologous hematopoietic stem cell transplantation (AHSCT) from a single Brazilian center. Bone marrow transplantation 55 (6) (2019)
Ujjawal H Gandhi, Robert F Cornell, Arjun Lakshman, Zhubin J Gahvari, Elizabeth McGehee, Megan H Jagosky, Ridhi Gupta, William Varnado, Mark A Fiala, Saurabh Chhabra, Ehsan Malek, Joshua Mansour, Barry Paul, Alyssa Barnstead, Saranya Kodali, Amarendra Neppalli, Michaela Liedtke, Swapna Narayana, Kelly N Godby, Yubin Kang, Ankit Kansagra, Elvira Umyarova, Emma C Scott, Parameswaran Hari, Ravi Vij, Saad Z Usmani, Natalie S Callander, Shaji K Kumar, Luciano José Megale Costa
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy. Leukemia 33 (9) (2019)
Kelli Borges Dos Santos, Luciano José Megale Costa, Gustavo Bettarello, Marcus da Matta Abreu, Graziela Toledo Costa Mayrink, Mariza Aparecida Mota, Luiz Cláudio Ribeiro, Juliana Pereira, Abrahão Elias Hallack Neto
LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma. Bone marrow transplantation 54 (4) (2018)
Caryn Sorge, Luciano José Megale Costa, Jeffrey W Taub, Mitchell S Cairo, Ana C Xavier
Incidence and outcomes of rare paediatric non-hodgkin lymphomas. British journal of haematology 184 (5) (2018)
Luciano José Megale Costa, Kelly N Godby, Saurabh Chhabra, Robert Frank Cornell, Parameswaran Hari, Smita Bhatia
Second primary malignancy after multiple myeloma-population trends and cause-specific mortality. British journal of haematology 182 (4) (2018)
Ayman Saad, Alankrita Taneja, Antonio Di Stasi, Rehan Sarmad, Rivvi Kukkamalla, Luciano José Megale Costa, Donna Salzman, Racquel Innis-Shelton, Joseph H Chewning, Ruby F Meredith, Vera Hauptfeld, Samantha Langford, KirbyAnn Plessala, Ravi Bhatia, Lawrence S Lamb, Shin Mineishi
Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant. Bone marrow transplantation 53 (10) (2018)
Nirav N Shah, Aniko Szabo, Scott F Huntington, Narendranath Epperla, Nishitha Reddy, Siddhartha Ganguly, Julie Vose, Cynthia Obiozor, Fahad Faruqi, Alexandra E Kovach, Luciano José Megale Costa, Ana C Xavier, Ryan Okal, Abraham S Kanate, Nilanjan Ghosh, Mohamed A Kharfan-Dabaja, Lauren Strelec, Mehdi Hamadani, Timothy S Fenske, Oscar Calzada, Jonathon B Cohen, Julio Chavez, Jakub Svoboda
R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis. British journal of haematology 180 (4) (2017)
Ana C Xavier, Narendranath Epperla, Jeffrey W Taub, Luciano José Megale Costa
Excess mortality among 10-year survivors of classical Hodgkin lymphoma in adolescents and young adults. American journal of hematology 93 (2) (2017)

Luciano José Megale Costa.css-eqlu8i{font-size:small;padding-left:4px;} (Luciano J Costa, Luciano Costa)

Publication Activity (10 Years)

Top Topics

Top Venues

Luciano José Megale Costa (Luciano J Costa, Luciano Costa)